메뉴 건너뛰기




Volumn 13, Issue 10, 2011, Pages 963-964

Phentermine therapy for obesity does not elevate blood pressure

Author keywords

[No Author keywords available]

Indexed keywords

AMFEPRAMONE; PHENDIMETRAZINE; PHENTERMINE; PHENTERMINE PLUS TOPIRAMATE;

EID: 80052544147     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01435.x     Document Type: Letter
Times cited : (6)

References (9)
  • 1
    • 77956154899 scopus 로고    scopus 로고
    • Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity.
    • Kang JG, Park CY, Kang JH, Park YW, Park SW. Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity. Diabetes Obes Metab 2010; 12: 876-882.
    • (2010) Diabetes Obes Metab , vol.12 , pp. 876-882
    • Kang, J.G.1    Park, C.Y.2    Kang, J.H.3    Park, Y.W.4    Park, S.W.5
  • 2
    • 70349695858 scopus 로고    scopus 로고
    • Long-term weight loss from lifestyle intervention benefits blood pressure? a systematic review
    • Aucott L, Rothnie H, McIntyre L, Thapa M, Waweru C, Gray D. Long-term weight loss from lifestyle intervention benefits blood pressure? a systematic review. Hypertension 2009; 54: 756-762.
    • (2009) Hypertension , vol.54 , pp. 756-762
    • Aucott, L.1    Rothnie, H.2    McIntyre, L.3    Thapa, M.4    Waweru, C.5    Gray, D.6
  • 3
    • 78649644149 scopus 로고    scopus 로고
    • Treatment of obesity with "combination" pharmacotherapy.
    • Rothman RB. Treatment of obesity with "combination" pharmacotherapy. Am J Ther 2010; 17: 596-603.
    • (2010) Am J Ther , vol.17 , pp. 596-603
    • Rothman, R.B.1
  • 4
    • 81855194456 scopus 로고    scopus 로고
    • Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity.
    • Epub ahead of print].
    • Hendricks EJ, Greenway FL, Westman EC, Gupta AK. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity. Obesity (Silver Spring) 2011 [Epub ahead of print].
    • (2011) Obesity (Silver Spring)
    • Hendricks, E.J.1    Greenway, F.L.2    Westman, E.C.3    Gupta, A.K.4
  • 5
    • 79954561234 scopus 로고    scopus 로고
    • Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.
    • Gadde KM, Allison DB, Ryan DH et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet 2011; 377: 1341-1352.
    • (2011) Lancet , vol.377 , pp. 1341-1352
    • Gadde, K.M.1    Allison, D.B.2    Ryan, D.H.3
  • 6
    • 24644477445 scopus 로고    scopus 로고
    • Anorectics on trial: a half century of federal regulation of prescription appetite suppressants.
    • Colman E. Anorectics on trial: a half century of federal regulation of prescription appetite suppressants. Ann Intern Med 2005; 143: 380-385.
    • (2005) Ann Intern Med , vol.143 , pp. 380-385
    • Colman, E.1
  • 7
    • 0026593859 scopus 로고
    • Long-term weight control study: conclusions.
    • Weintraub M. Long-term weight control study: conclusions. Clin Pharmacol Ther 1992; 51: 642-646.
    • (1992) Clin Pharmacol Ther , vol.51 , pp. 642-646
    • Weintraub, M.1
  • 8
    • 0017083601 scopus 로고
    • Anorectic drugs: use in general practice.
    • Craddock D. Anorectic drugs: use in general practice. Drugs 1976; 11: 378-393.
    • (1976) Drugs , vol.11 , pp. 378-393
    • Craddock, D.1
  • 9
    • 69749110806 scopus 로고    scopus 로고
    • How physician obesity specialists use drugs to treat obesity.
    • Hendricks EJ, Rothman RB, Greenway FL. How physician obesity specialists use drugs to treat obesity. Obesity 2009; 17: 1730-1735.
    • (2009) Obesity , vol.17 , pp. 1730-1735
    • Hendricks, E.J.1    Rothman, R.B.2    Greenway, F.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.